Blood News and Research

RSS

Immune response elicited by SARS-CoV-2 vaccines in infliximab and vedolizumab-treated patients with IBD

A recent study evaluates the immune responses elicited by COVID-19 vaccines in infliximab- or vedolizumab-treated IBD patients.

15 Nov 2021

Simple risk score can help predict contrast-associated kidney injury after PCI

A new, updated risk score can help predict possible contrast-associated acute kidney injury (CA-AKI) among patients undergoing percutaneous coronary intervention (PCI), Mount Sinai researchers report.

15 Nov 2021

Promising results from Phase II REGEN-COV study

Initial results of the REGEN-COV Phase II study are presented.

15 Nov 2021

Oral PCSK9-inhibitor highly effective at reducing high levels of LDL cholesterol, studies show

Results from two early clinical studies show the first version of an oral PCSK9-inhibitor cholesterol-lowering medicine was well tolerated and highly effective at reducing high levels of LDL cholesterol, according to late-breaking research presented today at the American Heart Association's Scientific Sessions 2021.

15 Nov 2021

Common hypertension drug not effective in slowing down the progression of Alzheimer's disease

New research led by the University of Bristol, has shown the drug losartan, normally used to treat high blood pressure (hypertension), is not effective in slowing down the progression of Alzheimer's disease (AD) in people with mild-to-moderate disease after 12 months of treatment.

15 Nov 2021

Study analyzes the health effects of a patented DGA compound

A study conducted at the University of Jyväskylä analyzed the health effects of a patented DGA compound and compared them to the effects of exercise.

15 Nov 2021

Racial or ethnic group of patients with diabetes influences prognosis of the disease

Professor and researcher of the Faculty of Nursing and Podiatry of the UV, Yasmín Ezzatvar, together with researchers from other centers, concludes that the racial or ethnic group of patients with type 1 and 2 diabetes mellitus influences the prognosis of the disease, due to differences in mortality, risk of kidney disease or risk of cardiovascular disease.

15 Nov 2021

Stem cell treatment reduced deaths related to cardiovascular issues, not hospitalization

Stem cell therapy helped to reduce the number of heart attacks, strokes and death among people with chronic, high-risk, NYHA class II or III heart failure with reduced ejection fraction (HFrEF), especially among those who have higher levels of inflammation, yet hospitalization was not reduced, according to late-breaking research presented today at the American Heart Association's Scientific Sessions 2021.

15 Nov 2021

Study finds beneficial and harmful short-term health effects of caffeinated coffee consumption

Drinking caffeinated coffee appears to have both beneficial and harmful short-term health effects: increased abnormal heartbeats, increased physical activity and reduced sleep duration, according to late-breaking research presented today at the American Heart Association's Scientific Sessions 2021.

15 Nov 2021

Valve replacement surgery may be beneficial for patients with asymptomatic severe aortic stenosis

For people experiencing severe aortic stenosis who do not have symptoms or need symptom relief, early aortic valve replacement surgery may be beneficial because it reduces the risk of death, heart attack, stroke and heart failure, according to late-breaking research presented today at the American Heart Association's Scientific Sessions 2021.

15 Nov 2021

Posterior left pericardiotomy linked to prevention of atrial fibrillation after cardiac surgery

A simple surgical technique during cardiac surgery was associated with a 56 percent reduction in the incidence of an irregular heart rhythm known as atrial fibrillation that can lead to stroke, with no added risks or side effects, according to a new study by Weill Cornell Medicine and NewYork-Presbyterian investigators.

15 Nov 2021

Anti-platelet drug class fails to extend survival in moderately ill COVID-19 patients

A drug class that blocks the activity of blood platelets and prevents clotting—P2Y12 inhibitors—failed to extend survival or lessen disease severity in patients with COVID-19 who were hospitalized but had a relatively moderate case, a new study finds.

15 Nov 2021

Long-term study begins to evaluate COVID-19's effects on the overall health of children

A large, long-term study of the impacts of COVID-19 on children has enrolled its first participant at the National Institutes of Health's Clinical Center in Bethesda, Maryland.

15 Nov 2021

New therapy targets rodents' cells rather than bacterial cells in treating pneumonia

Researchers at the National Institutes of Health have discovered a therapy that targets host cells rather than bacterial cells in treating bacterial pneumonia in rodents.

15 Nov 2021

Could drugs derived from microalgae be effective against COVID-19?

Researchers discuss the ability of some microalgae metabolites to prevent cytokine storm syndrome during COVID-19.

15 Nov 2021

SARS-CoV-2 infection inhibited by CCR2 signaling

A new study discusses the role of monocytes in protecting individuals from SARS-CoV-2.

15 Nov 2021

Potential biomarkers of coagulopathy and disease severity in COVID-19

Scientists have investigated the presence of specific biomarkers in hospitalized COVID-19 patients

15 Nov 2021

New WHO report highlights the alarming state of global access to insulin and diabetes care

A new report published by WHO in the lead-up to World Diabetes Day highlights the alarming state of global access to insulin and diabetes care, and finds that high prices, low availability of human insulin, few producers dominating the insulin market and weak health systems are the main barriers to universal access.

15 Nov 2021

Tracking potential triggers of atrial fibrillation could lead to fewer episodes

People with atrial fibrillation who underwent individualized testing to discover triggers for their irregular heartbeats reported less frequent irregular episodes, according to late-breaking research presented today at the American Heart Association's Scientific Sessions 2021.

15 Nov 2021

Anticoagulation treatment may prevent cognitive decline in older atrial fibrillation patients

The anticoagulant medication dabigatran yielded similar results to warfarin for the prevention of cognitive decline in older adults with atrial fibrillation after two years of treatment, according to late-breaking research presented today at the American Heart Association's Scientific Sessions 2021.

15 Nov 2021

Blood News and Research

Immune response elicited by SARS-CoV-2 vaccines in infliximab and vedolizumab-treated patients with IBD

Simple risk score can help predict contrast-associated kidney injury after PCI

Promising results from Phase II REGEN-COV study

Oral PCSK9-inhibitor highly effective at reducing high levels of LDL cholesterol, studies show

Common hypertension drug not effective in slowing down the progression of Alzheimer's disease

Study analyzes the health effects of a patented DGA compound

Racial or ethnic group of patients with diabetes influences prognosis of the disease

Stem cell treatment reduced deaths related to cardiovascular issues, not hospitalization

Study finds beneficial and harmful short-term health effects of caffeinated coffee consumption

Valve replacement surgery may be beneficial for patients with asymptomatic severe aortic stenosis

Posterior left pericardiotomy linked to prevention of atrial fibrillation after cardiac surgery

Anti-platelet drug class fails to extend survival in moderately ill COVID-19 patients

Long-term study begins to evaluate COVID-19's effects on the overall health of children

New therapy targets rodents' cells rather than bacterial cells in treating pneumonia

Could drugs derived from microalgae be effective against COVID-19?

SARS-CoV-2 infection inhibited by CCR2 signaling

Potential biomarkers of coagulopathy and disease severity in COVID-19

New WHO report highlights the alarming state of global access to insulin and diabetes care

Tracking potential triggers of atrial fibrillation could lead to fewer episodes

Anticoagulation treatment may prevent cognitive decline in older atrial fibrillation patients

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News